Frederic Blanc1, Nathalie Philippi1, Benjamin Cretin1, Catherine Kleitz2, Laetitia Berly2, Barbara Jung1, Stephane Kremer3, Izzie Jacques Namer4, François Sellal5, Benoit Jaulhac6, Jerome de Seze7. 1. University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service, Strasbourg, France University of Strasbourg and CNRS, ICube Laboratory and FMTS (Fédération de Médecine Translationnelle de Strasbourg) Strasbourg, France University Hospital of Strasbourg, CMRR (Memory Resource and Research Center), Strasbourg, France. 2. University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service, Strasbourg, France University Hospital of Strasbourg, CMRR (Memory Resource and Research Center), Strasbourg, France. 3. University of Strasbourg and CNRS, ICube Laboratory and FMTS (Fédération de Médecine Translationnelle de Strasbourg) Strasbourg, France University Hospital of Strasbourg, Neuroradiology Service, Strasbourg, France. 4. University of Strasbourg and CNRS, ICube Laboratory and FMTS (Fédération de Médecine Translationnelle de Strasbourg) Strasbourg, France University Hospital of Strasbourg, Nuclear Medicine Service, Strasbourg, France. 5. University Hospital of Strasbourg, CMRR (Memory Resource and Research Center), Strasbourg, France General Hospital of Colmar, Neurology Service, Colmar, France. 6. University Hospital of Strasbourg, Laboratory of Bacteriology and National Center for Borrelia, Strasbourg, France. 7. University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service, Strasbourg, France INSERM U119, Strasbourg, France.
Abstract
INTRODUCTION: Descriptions of Lyme disease and dementia are rare. OBJECTIVE: To describe patients with dementia and a positive "intrathecal anti-Borrelia antibody index" (AI), specific for neuroborreliosis. METHODS: Among 1,594 patients seen for dementia, we prospectively identified and studied 20 patients (1.25%) with dementia and a positive AI. Patients underwent a battery of neuropsychological tests brain, MRI, FDG-PET, and cerebrospinal fluid (CSF) analysis. An etiological diagnosis of the dementia was made at the end of the follow-up of 5.0 ± 2.9 years. RESULTS: We found two groups of patients with dementia, the first (n = 7, 0.44%) with certain neuroborreliosis and stability or mild improvement of dementia after treatment by antibiotics and the second (n = 13, 0.81%) with progressive worsening of dementia, despite the antibiotics. In the second group, the final diagnoses were Alzheimer's disease (AD) (n = 4), AD and Lewy body disease (LBD) (n = 3), LBD (n = 1), FTLD (n = 3), hippocampal sclerosis (n = 1), and vascular dementia (n = 1). We did not observe any differences in cognitive test between the two patient groups at baseline. Brain MRI showed more focal atrophy and FDG-PET showed more frontal hypometabolism in the second group. Tau, p-tau, and Aβ42 concentrations in the CSF were normal in the neuroborreliosis group, and coherent with diagnosis in the second. CONCLUSION: Pure Lyme dementia exists and has a good outcome after antibiotics. It is advisable to do Lyme serology in demented patients, and if serology is positive, to do CSF analysis with AI. Neurodegenerative dementia associated with positive AI also exists, which may have been revealed by the involvement of Borrelia in the CNS.
INTRODUCTION: Descriptions of Lyme disease and dementia are rare. OBJECTIVE: To describe patients with dementia and a positive "intrathecal anti-Borrelia antibody index" (AI), specific for neuroborreliosis. METHODS: Among 1,594 patients seen for dementia, we prospectively identified and studied 20 patients (1.25%) with dementia and a positive AI. Patients underwent a battery of neuropsychological tests brain, MRI, FDG-PET, and cerebrospinal fluid (CSF) analysis. An etiological diagnosis of the dementia was made at the end of the follow-up of 5.0 ± 2.9 years. RESULTS: We found two groups of patients with dementia, the first (n = 7, 0.44%) with certain neuroborreliosis and stability or mild improvement of dementia after treatment by antibiotics and the second (n = 13, 0.81%) with progressive worsening of dementia, despite the antibiotics. In the second group, the final diagnoses were Alzheimer's disease (AD) (n = 4), AD and Lewy body disease (LBD) (n = 3), LBD (n = 1), FTLD (n = 3), hippocampal sclerosis (n = 1), and vascular dementia (n = 1). We did not observe any differences in cognitive test between the two patient groups at baseline. Brain MRI showed more focal atrophy and FDG-PET showed more frontal hypometabolism in the second group. Tau, p-tau, and Aβ42 concentrations in the CSF were normal in the neuroborreliosis group, and coherent with diagnosis in the second. CONCLUSION: Pure Lyme dementia exists and has a good outcome after antibiotics. It is advisable to do Lyme serology in demented patients, and if serology is positive, to do CSF analysis with AI. Neurodegenerative dementia associated with positive AI also exists, which may have been revealed by the involvement of Borrelia in the CNS.
Authors: Wolfgang Kristoferitsch; Fahmy Aboulenein-Djamshidian; Julia Jecel; Helmut Rauschka; Michael Rainer; Gerold Stanek; Peter Fischer Journal: Wien Klin Wochenschr Date: 2018-07-25 Impact factor: 1.704
Authors: Alireza G Senejani; Jasmin Maghsoudlou; Dina El-Zohiry; Gauri Gaur; Keith Wawrzeniak; Cristina Caravaglia; Vishwa A Khatri; Alan MacDonald; Eva Sapi Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.472
Authors: Shiva Kumar Goud Gadila; Gorazd Rosoklija; Andrew J Dwork; Brian A Fallon; Monica E Embers Journal: Front Neurol Date: 2021-05-10 Impact factor: 4.003